Jordan Siemens/DigitalVision via Getty Images Introduction My first view of Columbia Sportswear Company ( COLM ) revealed a stable business. They have a clean balance sheet and strong brand recognition. After a bit of digging it became clear that it might not be as perfect as initially perceived. Management launched the ACCELERATE strategy hoping to rejuvenate the company. Unfortunately, this has not resulted in groundbreaking results yet. The company’s growth has slowed and margins are starting to weaken. The company has to rely on international markets to offset the weakness in U.S. demand. Growth is remaining uneven, even with Q1 results being ahead of management's quarterly guidance. The clean balance sheet and shareholder returns help to limit downside risk. A more bullish stance cannot be supported by the current revenue growth and margin trend. For this reason, I view the stock as a Hold. Business Overview Columbia is an outdoor and activewear company. They sell globally in over 115 countries through channels such as wholesale and DTC. Most of their products are being manufactured by third-party suppliers who are mainly located in Asia. This helps to keep costs flexible, but there is no avoiding tariffs and supply chain risks. Financial Performance As I mentioned, recent financial performance indicated that the business is fairly stable. Unfortunately they are not showing meaningful growth. The Net sales in Q1 2026 were flat Y.o.Y at $779 million. International markets carried growth with a 16% increase Y.o.Y while the U.S. sales declined 10%. The international markets are currently representing 40% of the total sales. You would expect sales to be booming as a result of the ACCELERATE strategy, but this is not the case. It is clear that the issue is uneven growth. As the U.S , which is the core segment, continues to lag, growth is increasingly dependent on international markets. For me this also raises questions on the quality of the growth that is achieved. ...

格隆汇5月7日｜据边海纵横，2026年5月7日，外交部东黄海事务代表郭燕与韩国外交部国际法律局局长李奭周在中国成都共同主持中韩海域划界谈判工作组第十五轮会谈。双方就海域划界有关问题坦诚深入交换意见，并同意适时举行工作组第十六轮会谈。

The rise of agentic AI could lead to companies attaining billion-dollar valuations with very few employees.

It was an unusual Sunday for 30-year-old Jake Yi , who stood with his team in the middle of a Mumbai trading floor as the screens flashed red. The team had assembled for a special trading session to mark India's budget day, and they watched as stock prices tumbled in response to a new securities transaction tax. Yi, the head of India index options at IMC Trading BV, used the selloff as a teaching moment for the firm's crop of young traders — talking through spreads and risk in real time. These were the moments that mattered most: When volatility stripped away theory and forced decisions. For a young trader, there was no better classroom than a sharp market turn. These high‑pressure episodes have become the backbone of how high‑frequency firm IMC trains local talent when it enters a new market. India may offer one of the world’s biggest growth opportunities, but hiring is not easy. Rising competition, intense regulatory scrutiny and an increasingly complex trading environment means mistakes are easier to make -- and often harder to fix. To crack India’s fledgling high‑frequency trading market, IMC is building its own talent pipeline — making it one of the biggest spenders among global firms for local talent. The firm's formula is simple: The company brings veterans from overseas offices to turn fresh-faced math and coding wizards into skilled traders and developers. Expats now make up about 20% of the firm’s India staff. India is the fourth largest office by headcount for IMC after Chicago, Amsterdam and Sydney. The India unit was valued at 42.7 billion rupees ($451 million) based on an estimated 10 times price-to-earnings ratio for 2025, according to a regulatory filing. The firm projected 4.27 billion rupees in profit for last year. That figure would still put it far behind Citadel Securities LLC’s local earnings of 20.6 billion rupees for the 12 months ended March 2025. But IMC's earnings are growing at a fast clip — an estimated pace of 78% in one year, according...

格隆汇5月7日｜乌克兰首席谈判代表乌梅罗夫正在迈阿密与美国代表进行会谈。

Assessing Oracle’s (ORCL) AI Infrastructure Investment and Its Impact on Debt Ratios Yahoo Finance

White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. In the tough and volatile first quarter, White Falcon delivered a net return of -6.1%, vs. the S&P 500 TR’s (CAD) -3.1%, MSCI AC TR’s (CAD) -0.6%, and the S&P TSX TR’s 4.0% returns. A copy of the letter is available […]

With US equities regaining momentum amid easing tensions in the Middle East, questions are being raised as to whether global capital is rotating back into the world’s largest market. Investment advisers and fund managers said global investors were reassessing their asset allocations, though there was little evidence of a broad capital rotation away from Asia. While market performance suggested some reallocation, flow data remained inconclusive and did not point to a decisive shift away from...

【热点导读】 下游新兴产业需求加速释放，国内机床行业持续回暖 月之暗面完成约20亿美元融资，投后估值超200亿美元 电力设备产业链上市公司近期密集发布中标喜讯 和英伟达“站在光里”！康宁拟十倍扩产光连接产能 5月国内外商业航天产业有望迎来密集催化 【主题详情】 下游新兴产业需求加速释放，国内机床行业持续回暖 2026年，随着国内经济进一步向好，以及下游新兴产业的加工设备需求加速释放，国内机床行业持续回暖，据MIR数据，2026Q1我国金属切削机床市场规模超180亿元，同比增长超10%。 2026年开年以来，国内机床企业订单增长显著。多家机床生产企业正积极扩大产能，开足马力赶订单。下游新兴产业需求爆发，成为行业繁荣的核心驱动力：新能源汽车的电池壳体、电机转子加工，人形机器人的精密减速器制造，低空经济的碳纤维构件加工，均对高端五轴机床、精密加工设备提出刚性需求。江海证券认为，随着国内新兴产业加速发展，本土企业在技术创新、产品质量及配套服务能力上持续精进，我国机床产业有望在提升国内中高端市场占有率的同时，进一步获得海外市场的认可，最终实现在国际中高端机床市场占据重要地位。 上市公司中， 创世纪 的五轴加工中心、卧式加工中心等产品可用于航空航天领域相关的发动机叶片、机匣、机翼梁、口座、支架等结构件的精密加工，覆盖从发动机核心部件到机身大型结构件的全品类。 科德数控 的五轴数控机床已在航空航天等重点领域实现批量化进口替代。 月之暗面完成约20亿美元融资，投后估值超200亿美元 据华峰资本消息，月之暗面（Kimi）已完成新一轮约20亿美元融资，投后估值超200亿美元。本轮由美团龙珠领投，水木资本、中国移动、CPE（中信产业基金）等参投。华峰资本担任本次交易部分买方的财务顾问，在交易结构设计、投资方匹配及谈判中提供支持。 公开资料显示，Kimi核心团队由清华大学交叉信息研究院助理教授杨植麟领衔，核心成员多来自谷歌、Meta等国际科技巨头，其推出的长文本处理技术已形成差异化竞争优势。平安证券闫磊认为，国产大模型竞争加剧，阿里、月之暗面、DeepSeek等国内厂商密集发布AI大模型，显示出国产大模型争夺流量和构建AI超级应用的紧迫性。当前我国国产大模型持续迭代，能力持续提升，将进一步推动国产大模型从“可用”到“好用”，加快国产大模型在千行百业应用场景的落地，加快我国大模型产业的发展。...

Porsche is known for building cars that really are extremely good right out of the box. Yes, they tend to be more expensive than the other German luxury car brands, particularly once the option list comes out. But it doesn't take very long behind the wheel before the driving experience reveals why. And that's just the regular models; the stuff that comes out of the motorsport department in Wiessach—like the sublime 911 GT3 —is even more focused. But for some drivers, those who choose to spend their spare time enjoying track days at places like the legendary Nürburgring Nordschleife in Germany's Eifel Mountains, even cars like the razor-sharp GT3 RS make too many compromises for the road. For those people, there is Manthey Racing. Based at the industrial estate alongside the 'Ring, Manthey is a highly successful racing team—majority-owned by Porsche since 2013—that applies its years of experience making Porsches go even faster around the 12.9-mile (20.8 km) circuit known as the Green Hell to create upgrade kits that will turn the dials all the way up to 11. Read full article Comments

Seagate has become a critical enabler of hyperscale and AI-driven data infrastructure. In this episode of the Tech Disruptors podcast, CEO Dave Mosley tells Bloomberg Intelligence analyst Woo Jin Ho how storage demand is evolving with cloud and AI workloads, from nearline hard-disk-drive adoption to next-generation technologies such as HAMR. The podcast also explores how AI is reshaping storage architecture and data growth, Seagate’s approach to supply discipline and margin expansion and how com

“I think this is going to be the most eventful ASCO for biotech in a while,” says Dr. Roderick Wong, founder of RTW Investments, referring to the annual meeting of the American Society of Clinical Oncology. Wong joins Bloomberg Intelligence analyst Sam Fazeli on the Vanguards of Health Care podcast to break down biotech’s rebound, why fundamentals may finally be improving after a prolonged bear market and how China’s speed and cost advantages are reshaping global drug discovery. They also explor

AI has taken the corporate quest for efficiency to a new level — and it’s middle managers who seem to be getting left behind.

CHICAGO, May 07, 2026 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the first quarter and full year 2026.

FDA accepted the new drug application (NDA) for ulixacaltamide in Essential Tremor with a PDUFA target action date of January 29, 2027, and the NDA for relutrigine, with priority review, in SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) with a PDUFA target action date of September 27, 2026

CAMBRIDGE, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results for the quarter ended March 31, 2026 and provided a business update.

Results from Phase 2 trial of once-weekly canvuparatide accepted for oral presentation at ENDO in June 2026

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, today reported financial results for the first quarter ended March 31, 2026 and provided a business update on the development of simufilam, an oral small molecule intended to modulate filamin A protein.

ARD-101 and ARD-201 programs on voluntary pause; further guidance expected in Q2 2026

Aemetis Reports First Quarter 2026 Financial Results

First Quarter Delivers New Wins of $17 million, Margin Expansion, Strategic Investment Progress, and Early Signs of Cycle Recovery First Quarter Delivers New Wins of $17 million, Margin Expansion, Strategic Investment Progress, and Early Signs of Cycle Recovery

Rackspace Technology Reports First Quarter 2026 Results

Tom Werner/DigitalVision via Getty Images Co-authored by Kody's Dividends I find the Olympics to be an extremely interesting example of human achievement. For many of us, we don't commit ourselves to the level of dedication and focus that an Olympic-level athlete does to their sport. They will dedicate years or even decades to mastering a specific skill within a specific realm of humanity for the opportunity to compete against others who've done something similar on a world stage that gets actively or passively viewed by millions. I find it interesting to watch the Olympics at times and often only watch it passively, save for a few sports that I'm directly interested in. Yet the Olympics provide us with an opportunity to see what humans are capable of, both in greatness and in discouragement. In the 2020 Tokyo Olympics, there was an extreme moment of human achievement. Sifan Hassan, a runner from the Netherlands, was competing in the women's 1500-meter race and fell down in the final lap. There were only 300 meters left in the race, and she had tripped over another runner, which caused a number of people to fall in the middle of the pack. She needed to win to move on to the semifinals. She needed to not only get back up and keep running but also catch up to the leaders who were over 25 meters ahead of her at this point. Did she decide to fall and give up, or did she continue on? To the amazement of the crowd, she not only got back up and started running from the 13th spot out of 15 runners, but she also overtook the front runner and ended up in first place. It was an amazing moment in the Olympics and well worth watching if you want to go onto YouTube , because the moment went viral in 2020. When it comes to the stock market, companies have the ability to fall flat on their face or to give up when sentiment and sector shifts come. But management teams prove their quality when they're able to focus on what is working and work their plan to see success in the end. Tod...

The Good Brigade/DigitalVision via Getty Images Overview I last covered Ocular Therapeutix ( OCUL ) in December. This is a biopharma that is developing a TKI insert for wet AMD and NPDR. The insert is known as Axpaxli, which Ocular describes as an “investigational axitinib hydrogel administered by intravitreal injection.” The goal is to provide patients with symptom relief and reduce injection burden. When I last covered the company, it was right before its study in wet AMD that compared a single Axpaxli insert to a single low dose (relative to EYLEA HD) of aflibercept. Given that aflibercept is used much differently in the real world, I thought the trial set Axpaxli up for clinical success. But I didn't think that data from this trial would be relevant to retinal specialists. Moreover, I noted some competition. Ocular is not the only one developing a TKI insert for eye diseases. EyePoint Pharmaceuticals ( EYPT ) is also in late-stage trials for similar conditions (read my March 2026 analysis on EyePoint here ). Because I believed that TKI inserts have limited differentiation compared to current treatments, and Ocular had reached a market capitalization over $3 billion, I "pressed the brakes" on my recommendation, downgrading the stock from Buy to Hold. Image 1: Author's past recommendations on OCUL (Seeking Alpha) Since then, Ocular has reported wet AMD data and its first quarter earnings . Notably, the stock is 40% lower since my rating downgrade. Below, I take a closer look at the data and what's to come for Ocular. SOL-1 SOL-1 results were posted in mid-February. Axpaxli met the superiority primary endpoint in vision maintenance (loss less than 15 ETDRS letters) at Week 36 with a 74.1% versus 55.8%. After a year, the durability outcome was 65.9% versus 44.2%. Now, this study was conducted in treatment-naïve patients. Typically, these patients are easier to treat and respond better to drugs. Importantly, there were no treatment-related ocular severe adverse event...

Jian Fan/iStock via Getty Images The Xanadu Quantum Technologies Investment Thesis Xanadu Quantum Technologies ( XNDU ) is an interesting quantum company that is relatively new to the stock market. The company has an experienced leadership team and stands out from the competition thanks to its focus on photonics. While it is not yet possible to say which technology will ultimately prevail, Xanadu's roadmap sounds promising. I will definitely continue to keep an eye on Xanadu. But as I cannot currently say with high probability that their technology will be commercially successful, I can only give Xanadu a 'hold'. XNDU's Leadership Team Xanadu Quantum Technologies Investor Presentation In my opinion, it is very important for technology companies that are still in their infancy to have a strong leadership team. And that is the case with Xanadu. The founder and CEO has a PhD in photonic quantum computing, while the COO has experience as a data scientist. This is particularly important, as Xanadu could play a significant role in the interaction between AI and quantum computing. Pennylane , Xanadu's software offering, is a platform for quantum machine learning. Xanadu Quantum Technologies Investor Presentation And Pennylane also works with other quantum computing ecosystems, such as trapped ions or superconductors. So, even if Xanadu's photonics technology does not become widely adopted, there is still a possibility that Pennylane will become the go-to ecosystem for quantum AI and machine learning. I think this is a good move to secure a strong position for the future. Generally, I think the focus on software and hardware is beneficial. With Nvidia ( NVDA ) and CUDA, the importance of an ecosystem can be seen. If Xanadu succeeds in establishing an ecosystem for machine learning on quantum computers, this would be a huge long term competitive advantage. Photonics vs other quantum technologies Xanadu Quantum Technologies Investor Presentation In one of my articles about Io...

Iran Handshake Looks So Close, Semis Steal the Show, ARM and AMD Flex TheStreet Pro

Rackspace Technology and AMD Sign Memorandum of GlobeNewswire

Agreement underscores growing demand for flexible financing models to accelerate scale of AIcompute capacity ATLANTA, GA / ACCESS Newswire / May 7, 2026 / QumulusAI, a vertically integrated, hyper-distributed GPU cloud infrastructure company, today ...